MICA · FIRST-LINE LEARNING NOTES
Understand, prioritise and organise follow-up
Consider systemic disease when findings form a coherent pattern, while actively identifying organ involvement that requires prompt care.
Connect findings without forcing a label
Reconstruct the timeline of joint, skin, mucosal, vascular, neurological and constitutional findings. Purpura, Raynaud phenomenon, sicca symptoms, synovitis, weakness or pulmonary symptoms carry different meaning in different combinations. Consider infection, medicines and malignancy as alternatives. Multi-organ findings call for synthesis, not an automatic autoimmune diagnosis or an indiscriminate antibody panel.
[1][2]Look for clinically important silent involvement
Assess blood pressure, blood counts, kidney function and urine abnormalities when systemic disease is suspected; kidney involvement may cause few symptoms. Choose immunology according to phenotype, such as ANA and relevant specificities, or ANCA for a compatible presentation. A positive antibody does not establish disease; negative results do not exclude every form and require clinical interpretation.
[1][2]Look for coherent organ involvement rather than an isolated immunological signature. Skin, joint, kidney, lung or neurological features may guide testing, while infection and medication toxicity remain alternatives. Positive autoantibodies without compatible findings do not establish systemic disease. Compare urine findings, renal function and symptom evolution to identify threatening involvement.
[2][1]Recognise organ-threatening disease
Haemoptysis with breathlessness, rapidly worsening kidney function, new neurological deficit, necrotic purpura or ischaemia suggests potentially severe disease and requires urgent assessment. Suspected vasculitis with rapid kidney involvement must not wait through prolonged outpatient investigation. Biopsies and immunosuppressive treatment require specialist decisions that account for competing infection and opportunities to document the disease.
[2]- Haemoptysis with deteriorating renal function or urinary abnormalities requires urgent assessment.
- Avoid broad autoantibody panels without a clinical hypothesis and communicate context to the laboratory and specialist.
- Document organ involvement and alternatives before considering immunosuppression with the specialist team.
Share an actionable clinical summary
Provide dated symptoms, objective findings, treatments, laboratory results and available histology. Maintain a differential rather than prematurely asserting a diagnosis. After specialist review, clarify each clinician’s role and warning signs of disease activity or infection. New abnormalities should not automatically be attributed to a known systemic disease: comorbidity, toxicity and infection remain possible.
[1][2]A learning situation
FICTIONAL CASE · SELF-REFLECTION WITHOUT A SCORE
A 50-year-old woman has leg purpura, arthralgia and fatigue. Tests show rising creatinine and haematuria. She reports normal urination and wishes to wait several weeks for her scheduled appointment.
Does the absence of urinary symptoms justify waiting?
Read the reasoning
No. The kidney trajectory and extrarenal findings raise concern for systemic glomerular disease and require prompt assessment according to severity. Send dated results and check for other involvement, particularly pulmonary. Immunology and possible biopsy matter, but should not delay initial referral.
References and scope
- Executive summary: British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease ↗
- KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis ↗
Original educational synthesis for adult first-line practice. International references must be interpreted with the clinical setting and local care pathways. Independent human scientific review remains to be confirmed.